923281-52-1O=Cc1cc(Br)ccc1OC(F)(F)FIBEWLWBZTHFCPI-UHFFFAOYSA-N923281-52-1DTXSID70650253Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 6 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Uses5-Bromo-2-(trifluoromethoxy)benzaldehyde is used in the synthesis of (-)-epicatechin, synthesis of biologically active compounds in vitro.
PreparationAt 0 °C, a 1.6 mol/L hexane solution of n-butyllithium (15 mL) was added to a THF (50 mL) solution of diisopropylamine (3.5 mL). The reaction mixture was cooled to -78 °C, and 1-bromo-4-(trifluoromethoxy)benzene (6.0 g) was added. The mixture was stirred for 2 hours. Morpholine-4-carboxaldehyde (8.6 g) was then added to the reaction mixture, and the mixture was concentrated to dryness under reduced pressure. Water was added to the residue, and the mixture was extracted with ethyl acetate. The organic layer was washed with a saturated aqueous sodium bicarbonate solution, then with brine, dried over anhydrous magnesium sulfate, and concentrated. The residue was purified by silica gel column chromatography (solvent gradient; 0→30% ethyl acetate/hexane) to give 5-bromo-2-trifluoromethoxybenzaldehyde (5.04 g, 75%) as a colorless oil.